[Form 4] HELIOS TECHNOLOGIES, INC. Insider Trading Activity
Cary Chenanda, a director of Helios Technologies, Inc. (HLIO), was granted 742 restricted stock units (RSUs) on 09/18/2025. Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest on 09/18/2026 and have no expiration; the reported acquisition price is $0. After the grant, the reporting person beneficially owns 742 shares (direct). The Form 4 was signed by an attorney-in-fact on 09/19/2025 and reports the transaction as an individual filing by one reporting person.
- 742 RSUs granted, each representing one share of common stock, increasing reported direct beneficial ownership by 742 shares
- Vesting date disclosed as 09/18/2026 and the filing includes a signed attestation (09/19/2025)
- None.
Insights
TL;DR: Director received a routine equity grant of 742 RSUs, vesting in one year, increasing direct beneficial ownership by 742 shares.
This Form 4 documents a non-derivative equity award: 742 restricted stock units granted 09/18/2025, exercisable into one share each upon vesting 09/18/2026, with a reported price of $0 and 742 shares owned following the grant. The disclosure is consistent with standard director compensation practices and does not report sales, transfers, or exercised options. The filing is individual and signed by an attorney-in-fact.
TL;DR: The filing is a routine director RSU award; timing and structure are plainly disclosed with one-year vesting and direct ownership noted.
The Form 4 clearly states the nature of the award: restricted stock units converting one-for-one to common shares and vesting on 09/18/2026. The report identifies the reporting person as a director and shows direct beneficial ownership of 742 shares post-transaction. Documentation includes an attorney-in-fact signature dated 09/19/2025, meeting reporting formality requirements.